Lucid Diagnostics Inc (NASDAQ: LUCD) kicked off on Tuesday, down -1.60% from the previous trading day, before settling in for the closing price of $1.25. Over the past 52 weeks, LUCD has traded in a range of $0.68-$1.80.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 119.69% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 35.70%. With a float of $40.01 million, this company’s outstanding shares have now reached $63.07 million.
In an organization with 72 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -80.14%, operating margin of -1059.66%, and the pretax margin is -1047.61%.
Lucid Diagnostics Inc (LUCD) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Lucid Diagnostics Inc is 62.03%, while institutional ownership is 4.27%.
Lucid Diagnostics Inc (LUCD) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 35.70% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 40.08% during the next five years compared to -54.43% drop over the previous five years of trading.
Lucid Diagnostics Inc (NASDAQ: LUCD) Trading Performance Indicators
Take a look at Lucid Diagnostics Inc’s (LUCD) current performance indicators. Last quarter, stock had a quick ratio of 1.03. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 29.80.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.07, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.32 in one year’s time.
Technical Analysis of Lucid Diagnostics Inc (LUCD)
Let’s dig in a bit further. During the last 5-days, its volume was 0.76 million. That was inferior than the volume of 0.85 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 38.24%. Additionally, its Average True Range was 0.10.
During the past 100 days, Lucid Diagnostics Inc’s (LUCD) raw stochastic average was set at 45.71%, which indicates a significant decrease from 55.17% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 60.96% in the past 14 days, which was lower than the 85.54% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.3738, while its 200-day Moving Average is $1.0151. However, in the short run, Lucid Diagnostics Inc’s stock first resistance to watch stands at $1.2500. Second resistance stands at $1.2700. The third major resistance level sits at $1.2900. If the price goes on to break the first support level at $1.2100, it is likely to go to the next support level at $1.1900. Assuming the price breaks the second support level, the third support level stands at $1.1700.
Lucid Diagnostics Inc (NASDAQ: LUCD) Key Stats
The company with the Market Capitalisation of 129.62 million has total of 105,383K Shares Outstanding. Its annual sales at the moment are 4,350 K in contrast with the sum of -45,530 K annual income. Company’s last quarter sales were recorded 1,200 K and last quarter income was -11,540 K.
